Hannah Lee, MD
Gastroenterology · Richmond, VANPI 1275570988
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Eisai Inc. accounts for 68.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $105 and has fallen 71.9% since, to $29 in 2025. That places this record below the midpoint for gastroenterology clinicians in VA, where the typical reported total is $3,407.
Across 7 payments — averaging $35.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$172
- Medtronic$29
- Sun Pharmaceutical Industries Inc.$29
- Boston Scientific$21
Across 18 payments — averaging $4906.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$51K
- AstraZeneca$37K
What the payments were for
- Food & beverage$252100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 4 | $172 |
| Medtronic | 1 | $29 |
| Sun Pharmaceutical Industries Inc. | 1 | $29 |
| Boston Scientific | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LENVIMA$105
How this compares
$252 in reported general payments places this provider in the 15th percentile of 473 gastroenterology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NexavarSorafenib Tosylate | 11 | $184,713 |
| XifaxanRifaximin | 36 | $128,999 |
| LokelmaSodium Zirconium Cyclosilicate | 11 | $18,581 |
| Envarsus XrTacrolimus | 22 | $18,430 |
| Tacrolimus | 116 | $11,489 |
| Ursodiol | 27 | $5,255 |
| Mycophenolic AcidMycophenolate Sodium | 32 | $5,220 |
| Nadolol | 11 | $1,214 |
| Mycophenolate Mofetil | 20 | $782 |
| Spironolactone | 46 | $738 |
| Lactulose | 25 | $689 |
| Azathioprine | 11 | $641 |
| Pantoprazole Sodium | 42 | $495 |
| Entecavir | 15 | $477 |
| Trazodone Hcl | 26 | $231 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Richmond
- Arun SanyalRichmond$855K
- Michael FuchsRichmond$126K
- Michael ManetasRichmond$125K
- Jasmohan BajajRichmond$72K
- Binu JohnRichmond$33K
- Arthi SanjeeviRichmond$22K
- Henry EllettRichmond$22K
- Ray KeateRichmond$22K
- Tilak ShahRichmond$20K
- Joseph SpataroRichmond$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.